Koninklijke Philips Long-Term Investments 2010-2025 | PHG

Koninklijke Philips long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Koninklijke Philips long-term investments for the quarter ending March 31, 2025 were $0.260B, a 61.67% decline year-over-year.
  • Koninklijke Philips long-term investments for 2024 were $0.961B, a 133.03% increase from 2023.
  • Koninklijke Philips long-term investments for 2023 were $0.412B, a 27.66% decline from 2022.
  • Koninklijke Philips long-term investments for 2022 were $0.57B, a 12.57% increase from 2021.
Koninklijke Philips Annual Long-Term Investments
(Millions of US $)
2024 $961
2023 $412
2022 $570
2021 $506
2020 $274
2019 $262
2018 $289
2017 $185
2016 $276
2015 $265
2014 $209
2013 $214
2012 $228
2011 $283
2010 $240
2009 $392
Koninklijke Philips Quarterly Long-Term Investments
(Millions of US $)
2025-03-31 $260
2024-06-30 $311
2023-06-30 $508
2023-03-31
2022-06-30 $679
2021-06-30 $446
2020-06-30 $248
2019-06-30 $283
2018-06-30 $327
2017-06-30 $195
2016-12-31 $276
2016-09-30 $267
2016-06-30 $299
2016-03-31 $276
2015-12-31 $265
2015-09-30 $254
2015-06-30 $248
2015-03-31 $266
2014-12-31 $209
2014-09-30 $210
2014-06-30 $235
2014-03-31 $249
2013-12-31 $214
2013-09-30 $219
2013-06-30 $214
2013-03-31 $232
2012-12-31 $228
2012-09-30 $244
2012-06-30 $261
2012-03-31 $261
2011-12-31 $283
2011-09-30 $279
2011-06-30 $236
2011-03-31 $232
2010-12-31 $240
2010-09-30 $234
2010-06-30 $244
2010-03-31 $229
2009-12-31 $392
2009-09-30 $386
2009-06-30 $334
2009-03-31 $313
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.436B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.835B 28.36
Boston Scientific (BSX) United States $157.798B 39.50
Stryker (SYK) United States $150.649B 31.50
EssilorLuxottica (ESLOY) France $134.205B 0.00
Medtronic (MDT) Ireland $111.543B 16.29
Lonza Group Ag (LZAGY) Switzerland $49.908B 0.00
Haleon (HLN) United Kingdom $49.033B 27.90
ResMed (RMD) United States $37.148B 27.90
GE HealthCare Technologies (GEHC) United States $33.471B 15.89
Agilent Technologies (A) United States $32.342B 21.36
Terumo (TRUMY) Japan $27.583B 35.83
Insulet (PODD) United States $22.931B 90.01
Zimmer Biomet Holdings (ZBH) United States $18.948B 12.17
Baxter (BAX) United States $16.150B 12.06
Smith & Nephew SNATS (SNN) United Kingdom $12.745B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.231B 0.00
Bio-Rad Laboratories (BIO) United States $6.767B 23.55
Lantheus Holdings (LNTH) United States $5.414B 13.66
Prestige Consumer Healthcare (PBH) United States $4.395B 19.63
Perrigo (PRGO) Ireland $3.739B 9.48
Haemonetics (HAE) United States $3.484B 15.18
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.396B 25.05
Envista Holdings (NVST) United States $3.000B 24.93
QuidelOrtho (QDEL) United States $2.203B 15.15
GN Store Nord (GNNDY) Denmark $2.097B 17.37
LeMaitre Vascular (LMAT) United States $1.942B 43.41
AtriCure (ATRC) United States $1.604B 0.00
Neogen (NEOG) United States $1.389B 17.78
Kestra Medical Technologies (KMTS) United States $1.245B 0.00
AdaptHealth (AHCO) United States $1.213B 12.31
Green Thumb Industries (GTBIF) United States $1.175B 26.43
BioLife Solutions (BLFS) United States $1.090B 0.00
InMode (INMD) Israel $1.011B 9.25
Phibro Animal Health (PAHC) United States $0.978B 12.50
CeriBell (CBLL) United States $0.644B 0.00
Evolus (EOLS) United States $0.638B 0.00
Curaleaf Holdings (CURLF) Canada $0.566B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.553B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
Valneva SE (VALN) France $0.530B 0.00
Capricor Therapeutics (CAPR) United States $0.474B 0.00
Tilray Brands (TLRY) Canada $0.456B 0.00
Surmodics (SRDX) United States $0.422B 0.00
Cresco Labs (CRLBF) United States $0.349B 0.00
SNDL (SNDL) Canada $0.342B 0.00
VAREX IMAGING (VREX) United States $0.330B 12.14
Canopy Growth (CGC) Canada $0.302B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.300B 0.00
Aurora Cannabis (ACB) Canada $0.282B 50.20
Sanara MedTech (SMTI) United States $0.277B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
Sanuwave Health (SNWV) United States $0.253B 0.00
Cerus (CERS) United States $0.252B 0.00
Verano Holdings (VRNOF) United States $0.250B 0.00
ZimVie (ZIMV) United States $0.244B 11.08
Biote (BTMD) United States $0.222B 6.25
Brainsway (BWAY) Israel $0.201B 53.25
OraSure Technologies (OSUR) United States $0.197B 0.00
Omeros (OMER) United States $0.195B 0.00
High Tide (HITI) Canada $0.190B 0.00
Quanterix (QTRX) United States $0.189B 0.00
Utah Medical Products (UTMD) United States $0.177B 14.41
Organigram Global (OGI) Canada $0.175B 0.00
TriSalus Life Sciences (TLSI) United States $0.167B 0.00
Exagen (XGN) United States $0.135B 0.00
FitLife Brands (FTLF) United States $0.130B 15.94
Jin Medical (ZJYL) China $0.126B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
Agape ATP (ATPC) $0.102B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.084B 10.81
Veru (VERU) United States $0.076B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Quipt Home Medical (QIPT) United States $0.060B 0.00
United Health Products (UEEC) United States $0.058B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.050B 0.00
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.040B 13.69
Rockwell Medical (RMTI) United States $0.036B 0.00
Safety Shot (SHOT) United States $0.030B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
Nephros (NEPH) United States $0.023B 30.71
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Acuren (TIC) United States $0.000B 0.00